Curaleaf (OTCMKTS:CURLF) versus Akanda (NASDAQ:AKAN) Head to Head Comparison

Akanda (NASDAQ:AKAN) and Curaleaf (OTCMKTS:CURLF) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings for Akanda and Curaleaf, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Akanda	0	0	0	0	N/A
Curaleaf	0	0	1	0	3.00

Curaleaf has a consensus target price of $6.25, indicating a potential upside of 103.58%. Given Curaleaf’s higher probable upside, analysts clearly believe Curaleaf is more favorable than Akanda.

Valuation and Earnings

This table compares Akanda and Curaleaf”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Akanda	$2.16 million	0.11	-$32.28 million	N/A	N/A
Curaleaf	$1.35 billion	1.48	-$281.20 million	($0.39)	-7.87

Akanda has higher earnings, but lower revenue than Curaleaf.

Insider and Institutional Ownership

1.0% of Akanda shares are owned by institutional investors. Comparatively, 0.0% of Curaleaf shares are owned by institutional investors. 20.4% of Akanda shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Akanda and Curaleaf’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Akanda	N/A	N/A	N/A
Curaleaf	-18.59%	-14.75%	-5.19%

Risk and Volatility

Akanda has a beta of 1.45, indicating that its stock price is 45% more volatile than the S&P 500. Comparatively, Curaleaf has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500.

Summary

Akanda beats Curaleaf on 7 of the 11 factors compared between the two stocks.

About Akanda

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

About Curaleaf

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.